Nancy Boodhun joins Eclevar MedTech as Chief Clinical Operations & Strategy Officer.

Eclevar MedTech today announced the appointment of Nancy Boodhun as Chief Clinical Operations & Strategy Officer. With more than 25 years of experience across clinical research, regulatory strategy and global clinical operations, Nancy joins Eclevar to strengthen the company’s ability to design and deliver robust clinical evidence programs aligned with regulator expectations and manufacturers’ business objectives, while ensuring client needs are met through operational delivery.

Proven leadership in global clinical strategy

Nancy’s career spans the full spectrum of medical device clinical research, from strategic planning to operational delivery. Her experience from both a CRO and a manufacturer’s perspective gives her unique insight into what it takes to succeed in clinical projects. During a 12-year tenure at Johnson & Johnson she led global clinical strategies for orthopedic implants, managing complex Class III device studies from protocol development through key regulatory milestones, and provided oversight of investigator-initiated study portfolios.

Why this matters for Eclevar MedTech

Nancy’s appointment strengthens Eclevar’s ability to deliver world-class clinical operations and strategic evidence planning, particularly for complex device programs, clinical investigations and robust evidence generation, PMCF programs and post-market continuity.